Literature DB >> 10734124

Structural relationships and sialylation among meningococcal L1, L8, and L3,7 lipooligosaccharide serotypes.

J McLeod Griffiss1, B L Brandt, N B Saunders, W Zollinger.   

Abstract

Eighteen of 34 endemic meningococcal case strains were of the L8 lipooligosaccharide (LOS) type; four of these were both L3 and L7 (L3,7), and seven were L1. L1 structures arose by alternative terminal Gal substitutions of lactosyl diheptoside L8 structures, as determined by electrospray ionization and other mass spectrometric techniques, and enzymatic and chemical degradations (Structures L1 and L1a). [see text for structure] The more abundant molecule, designated L1, had a trihexose globosyl alpha chain; the less abundant one, designated L1a, had a beta-lactosyl alpha chain and a parallel alpha-lactosaminyl gamma chain. A P(k) globoside (Galalpha1-->4Galbeta1-->4 Glc-R) monoclonal antibody bound 9/10 L1 strains, but a P(1) globoside (Galalpha1-->4Galbeta1-->4GlcNAc-R) mAb bound none of them. alpha-Galactosidase caused loss of both L1 structures and creation of L8 structures; beta-galactosidase caused loss of the L8 determinant. The L1/P(k) glycose was partially sialylated. Some LOS also had unsubstituted basal beta-GlcNAc additions. These structural relationships explain co-expression of L8, L1, and L3,7 serotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734124     DOI: 10.1074/jbc.275.13.9716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Structural and immunochemical characterization of the lipooligosaccharides expressed by Neisseria subflava 44.

Authors:  Y Tong; V Reinhold; B Reinhold; B Brandt; D C Stein
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.

Authors:  Sanjay Ram; Sunita Gulati; Lisa A Lewis; Srinjoy Chakraborti; Bo Zheng; Rosane B DeOliveira; George W Reed; Andrew D Cox; Jianjun Li; Frank St Michael; Jacek Stupak; Xiao-Hong Su; Sudeshna Saha; Corinna S Landig; Ajit Varki; Peter A Rice
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

3.  Influence of the length of the lipooligosaccharide alpha chain on its sialylation in Neisseria meningitidis.

Authors:  Chao-Ming Tsai; George Kao; Peixuan Zhu
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.

Authors:  Deborah H Schmiel; Elizabeth E Moran; Paul B Keiser; Brenda L Brandt; Wendell D Zollinger
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

5.  Biochemical analysis of Lpt3, a protein responsible for phosphoethanolamine addition to lipooligosaccharide of pathogenic Neisseria.

Authors:  Ellen T O'Connor; Andrzej Piekarowicz; Karen V Swanson; J McLeod Griffiss; Daniel C Stein
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

6.  Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis.

Authors:  Michele M Estabrook; Gary A Jarvis; J McLeod Griffiss
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

7.  Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.

Authors:  Svein Rune Andersen; Terry Guthrie; Geoffrey R Guile; Jan Kolberg; Sam Hou; Lisa Hyland; Simon Y C Wong
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Human lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure.

Authors:  Hui Cheng; Zhijie Yang; Michele M Estabrook; Constance M John; Gary A Jarvis; Stephanie McLaughlin; J McLeod Griffiss
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

9.  Structural characterization of an oligosaccharide made by Neisseria sicca.

Authors:  Ellen T O'Connor; Hui Zhou; Kevin Bullock; Karen V Swanson; J McLeod Griffiss; Vernon N Reinhold; Clinton J Miller; Daniel C Stein
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

10.  Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.

Authors:  Srinjoy Chakraborti; Lisa A Lewis; Andrew D Cox; Frank St Michael; Jianjun Li; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2016-05-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.